{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-8934", "postId": 8934, "name": "Medpace Holdings, Inc.", "description": "If you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (\u201cMedpace\u201d or the \u201cCompany\u201d) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the true state of Medpace’s backlog cancellation rate. Defendants continuously touted “well behaved” cancellation rates. Furthermore, Medpace made clear that cancellations were not caused by weak business or a weak funding environment, providing investors with overly positive growth expectations that could not maintain the projected 1.15 book-to-bill ratio. Lead Plaintiff Deadline: June 8, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "MEDP", "legal": { "court": "United States District Court for the Southern District of Ohio", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "04/22/2025", "end": "02/09/2026" }, "leadPlaintiffDeadline": "06/08/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/medpace-holdings-inc/", "canonicalUrl": "https://faruqilaw.com/case/medpace-holdings-inc/", "datePublished": "2026-04-07T18:50:18+00:00", "dateModified": "2026-04-08T15:07:55+00:00", "associatedOrganization": { "@id": "case-8934-org" }, "legalService": { "@id": "case-8934-legalservice" }, "hasPart": [ { "@id": "case-8934-faq" }, { "@id": "case-8934-press-list" } ], "legalRepresentation": [ { "@id": "case-8934-attorney-516" }, { "@id": "case-8934-attorney-506" } ] }, { "@type": "Organization", "@id": "case-8934-org", "name": "Medpace Holdings, Inc.", "identifier": "MEDP", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://www.medpace.com/" }, { "@type": "LegalService", "@id": "case-8934-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-8934-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-8934-legalservice" } }, { "@type": "Person", "@id": "case-8934-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-8934-legalservice" } }, { "@type": "FAQPage", "@id": "case-8934-faq", "mainEntity": [ { "@type": "Question", "name": "What is the Medpace Holdings lawsuit about?", "acceptedAnswer": { "@type": "Answer", "text": "The Medpace lawsuit alleges the company misled investors by overstating the stability of its backlog and cancellation rates. It claims executives provided overly positive growth projections while concealing adverse trends, potentially violating federal securities laws." } }, { "@type": "Question", "name": "Who can join the Medpace investor lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased Medpace (NASDAQ: MEDP) securities during the relevant period and suffered financial losses may be eligible to participate. Those affected can seek to join the class action or apply to be lead plaintiff before the stated deadline." } }, { "@type": "Question", "name": "What is the deadline to file in the Medpace class action?", "acceptedAnswer": { "@type": "Answer", "text": "The deadline to seek lead plaintiff status in the Medpace securities class action is June 8, 2026. Investors must act before this date if they want a leadership role in representing the class in federal court proceedings." } }, { "@type": "Question", "name": "What are the main allegations against Medpace Holdings?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges Medpace issued false or misleading statements about backlog cancellation rates and business strength. It claims the company downplayed risks and promoted unrealistic growth expectations, including its projected book-to-bill ratio." } }, { "@type": "Question", "name": "What should Medpace investors do if they lost money?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who suffered losses in Medpace stock may consider contacting a securities law firm like Faruqi & Faruqi. They can review eligibility, understand legal options, and decide whether to join the lawsuit or seek lead plaintiff status." } } ] }, { "@type": "NewsArticle", "@id": "case-8934-press-1", "headline": "Medpace Holdings (MEDP) Is Down 23.1% After Mixed 2025 Results and 2026 Outlook - Has The Bull Case Changed?", "url": "https://finance.yahoo.com/news/medpace-holdings-medp-down-23-061116627.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAJ2Eu-cj_OsKwtufAqA4AO_R7z3xOIkZXBZPU7cNSrHJOQ4RpVrWdhwYdNSmhbxaAToCCo0h4fvLqvw6o7EFEJ-y7hvfFfYSZAkpcM3xOwXV2Gt_vq-worCZSNn70oqecn3j_oDWY_MViYu1frUXhFDxoVTovKM2csqm0n4cGGk7", "datePublished": "2026-02-13" }, { "@type": "NewsArticle", "@id": "case-8934-press-2", "headline": "Medpace Stock (-16%): Guidance Decel Sparks Institutional Selling", "url": "https://www.trefis.com/stock/medp/articles/590445/medpace-stock-16-guidance-decel-sparks-institutional-selling/2026-02-11", "datePublished": "2026-02-11" }, { "@type": "NewsArticle", "@id": "case-8934-press-3", "headline": "Medpace (MEDP) Shares Drop Despite Beating Q4 Expectations", "url": "https://www.gurufocus.com/news/8602897/medpace-medp-shares-drop-despite-beating-q4-expectations?mobile=true", "datePublished": "2026-02-10" }, { "@type": "ItemList", "@id": "case-8934-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-8934-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-8934-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-8934-press-3" } } ] } ] }

Medpace Holdings, Inc.

Medpace Holdings, Inc.

Join Action
Case Details
Ticker MEDP
Class Period 04/22/2025 - 02/09/2026
Lead Plaintiff Deadline 06/08/2026
Days Left to Seek Plaintiff
39

If you are a Medpace investor who suffered a loss and would like to learn more, you can provide your information below:

If you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the true state of Medpace’s backlog cancellation rate. Defendants continuously touted “well behaved” cancellation rates. Furthermore, Medpace made clear that cancellations were not caused by weak business or a weak funding environment, providing investors with overly positive growth expectations that could not maintain the projected 1.15 book-to-bill ratio.

📞 Lead Plaintiff Deadline: June 8, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
Medpace Holdings, Inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771